Surgery is often recommended for patients resistant to other therapies, and different techniques exist. Cultured melanocyte transplantation consists of the separation of epidermal cells obtained from a donor site and spreading these cells on the depigmented and dermabraded recipient area. This method allows for treatment of large, irregular areas. A repigmentation rate of 75-84% can be expected. Unfortunately, increased time for culture, special training, personnel, and equipment is needed. The same holds true for melanocyte keratinocyte transplant procedure. With this method, 84% repigmentation is possible. Another surgical technique is punch grafting, which is readily available, and does not require additional equipment or training. āUnfortunately, the cosmetic effect is poor, we often see a cobblestone-like effect, and typically adjuvant UV treatment is necessary,ā said Dr Hamzavi.
1. Hamzavi I. Session S002, AAD Annual Meeting, 1-5 March 2019, Washington DC, USA.
Posted on
Previous Article
« JAK-inhibitors: an emerging treatment option for vitiligo Next Article
Should we use more hormonal therapy? »
« JAK-inhibitors: an emerging treatment option for vitiligo Next Article
Should we use more hormonal therapy? »
Table of Contents: AAD 2019
Featured articles
Letter from the Editor
Interview with AAD president Prof. George J. Hruza
Late-Breakers
Secukinumab maintains improvements in psoriasis through 5 years of treatment
Bermekimab – a future treatment for atopic dermatitis?
JAK1/2 inhibitor effective in alopecia areata
Novel anti-IgE drug enables durable urticaria control
Dual IL-17A and IL-17F blocker leads to unprecedented response rates in psoriasis
Thicker AK lesions benefit from laser pretreatment with high channel density
New standardised cantharidin product against molluscum contagiosum efficacious in two phase 3 trials
Brutonās tyrosine kinase inhibitor highly effective in pemphigus vulgaris
Serlopitant reduces pruritus associated with psoriasis
Atopic Dermatitis: Many New Therapies in the Pipeline
New and emerging atopic dermatitis therapies
Food triggers eczema ā an imperturbable belief of patients
Psoriasis and Biologics: The Beat Goes On
Psoriasis and Biologics: The Beat Goes On
JAK Inhibitors: A New Frontier in Dermatology
JAK inhibitors: a new therapeutic tool for dermatologists
JAK inhibitors: a pathogenesis-directed therapy for alopecia areata
Can JAK inhibitors close the current therapeutic gap in AD?
Hair Loss: No Reason for Therapeutic Nihilism
Hair Loss: No Reason for Therapeutic Nihilism
Vitiligo: The Beginning of a New Era
Vitiligo in children
Surgical treatment for selected vitiligo cases
JAK-inhibitors: an emerging treatment option for vitiligo
What's New and Hot in Acne
Should we use more hormonal therapy?
Pearls of the Posters
Pemphigus patients prone to osteoporosis
Intralesional 5-fluorouracil induced high clearance rates in cutaneous squamous cell carcinoma
Related Articles
Ā© 2024 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy
HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com